Plain-English translation of NCT07524829 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether regular phone check-ins from a nurse can help detect and manage side effects faster in women being treated with cyclin-dependent kinase (CDK) inhibitors — a type of breast cancer medication. Some patients receiving this treatment experience side effects like low white blood cell counts, stomach problems, and fatigue that can make them skip doses or stop treatment. The study compares patients who get standard care plus scheduled phone calls from a nurse with patients who receive standard care alone.
Between regular doctor visits, side effects from this medication can develop and go unnoticed, leading patients to miss doses, reduce their dose, or stop treatment entirely. By checking in with patients more often through phone calls, nurses may be able to catch problems early and help patients stay on their full treatment plan.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive standard care alone or standard care plus scheduled phone calls from a nurse. If you're in the phone call group, the nurse will contact you regularly during your treatment to ask how you're feeling, check for any side effects, and provide support. The study involves women at multiple hospitals and treatment centers, and you'll need access to a phone or internet device for these remote nursing contacts.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Italy